Stocks and InvestingStocks and Investing
Thu, October 15, 2020
Wed, October 14, 2020
Tue, October 13, 2020
Mon, October 12, 2020
Sun, October 11, 2020
Fri, October 9, 2020

Robbie Marcus Maintained (ABT) at Buy with Increased Target to $125 on, Oct 9th, 2020


Published on 2024-10-27 14:15:55 - WOPRAI, Robbie Marcus
  Print publication without navigation


Robbie Marcus of JP Morgan, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $110 to $125 on, Oct 9th, 2020.

Robbie has made no other calls on ABT in the last 4 months.



There are 9 other peers that have a rating on ABT. Out of the 9 peers that are also analyzing ABT, 1 agrees with Robbie's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $110 on, Friday, July 17th, 2020


These are the ratings of the 8 analyists that currently disagree with Robbie


  • Rick Wise of "Stifel" Maintained at Strong Buy and Held Target at $115 on, Monday, September 28th, 2020
  • Mike Polark of "Wolfe Research" Initiated at Buy and Held Target at $124 on, Friday, September 11th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $136 on, Monday, August 31st, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Friday, August 28th, 2020
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $112 on, Thursday, August 27th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Thursday, August 27th, 2020
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $125 on, Thursday, July 23rd, 2020
  • John Sourbeer of "UBS" Maintained at Strong Buy with Increased Target to $110 on, Friday, July 17th, 2020